SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/359FE9E89D181BABA1843302B43AD20A2CDFCE1A9484E2E451C6AB6F24CF226075660F37B44C118B35800308BC225EC5>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/359FE9E89D181BABA1843302B43AD20A2CDFCE1A9484E2E451C6AB6F24CF226075660F37B44C118B35800308BC225EC5
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/359FE9E89D181BABA1843302B43AD20A2CDFCE1A9484E2E451C6AB6F24CF226075660F37B44C118B35800308BC225EC5
http://www.w3.org/2000/01/rdf-schema#comment
"Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington's disease."
xsd:string
http://purl.uniprot.org/uniprot/#_2DCB440DAF422BEC2FEC361AE1771FA320CF815484BD085B5FAB00278E56454F784CD064DA0743A5198299077D433D01
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/359FE9E89D181BABA1843302B43AD20A2CDFCE1A9484E2E451C6AB6F24CF226075660F37B44C118B35800308BC225EC5
http://purl.uniprot.org/uniprot/P48147
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/359FE9E89D181BABA1843302B43AD20A2CDFCE1A9484E2E451C6AB6F24CF226075660F37B44C118B35800308BC225EC5
http://purl.uniprot.org/uniprot/#_P48147-mappedCitation-31565846
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/359FE9E89D181BABA1843302B43AD20A2CDFCE1A9484E2E451C6AB6F24CF226075660F37B44C118B35800308BC225EC5